These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1445434)

  • 1. [The mechanism of anticholinesterase action of acetylene organophosphorus inhibitors].
    Brestkin AP; Zhukovskiĭ IuG; Moralev SN; Rozengart VI; Sochilina EE; Iagodina OV; Vikhreva LA; Godovikov NN; Kabachnik MI
    Bioorg Khim; 1992 Aug; 18(8):1067-72. PubMed ID: 1445434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of the "acetylene effect" during interaction of organophosphorus compounds with cholinesterases].
    Kabachnik MI; Godovikov NN; Vikhreva LA; Pudova TA; Brestkin AP; Rozengart VI
    Izv Akad Nauk Ser Biol; 1999; (5):517-26. PubMed ID: 10581870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major intermediates in organophosphate synthesis (PCl3, POCl3, PSCl3, and their diethyl esters) are anticholinesterase agents directly or on activation.
    Segall Y; Quistad GB; Sparks SE; Casida JE
    Chem Res Toxicol; 2003 Mar; 16(3):350-6. PubMed ID: 12641435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of substituted thiobutinylic esters of phosphorus thio acids and their saturated analogs on cholinesterases of different origins].
    Balashova EK; Brestkin AP; Vikhreva LA; Godovikov NN; Kabachnik MI
    Zh Evol Biokhim Fiziol; 1982; 18(4):325-9. PubMed ID: 7124204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction of dialkyl(alpha-carbomethoxy-beta,beta,beta-trifluoro- ethyl) phosphates with mammalian esterases].
    Makhaeva GF; Fetisov VI; Sokolov VB; Iankovskaia VL; Goreva TV
    Bioorg Khim; 1987 Jan; 13(1):33-7. PubMed ID: 3566818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and anticholinesterase activity of acetylene organophosphorus compounds].
    Balashova EK; Brestkin AP; Zhukovskiĭ IuG; Rozengart VI; Sherstobitov OE
    Dokl Akad Nauk SSSR; 1983; 272(2):503-6. PubMed ID: 6679836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formation of models of the interaction between organophosphate compound structure and their ability to inhibit cholinesterase].
    Raevskiĭ OA; Chistiakov VV; Agabekian RS; Sapegin AM; Zefirov NS
    Bioorg Khim; 1990 Nov; 16(11):1509-22. PubMed ID: 2096825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Finding cholinesterase in endotheliocytes: cholinesterase inhibition by organophosphorus compounds leads to endotheliocyte deformation].
    Prozorovskiĭ VB; Skopichev VG
    Eksp Klin Farmakol; 2005; 68(3):64-7. PubMed ID: 16047685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain cholinesterases. Differentiation of target enzymes for toxic organophosphorus compounds.
    Chemnitius JM; Haselmeyer KH; Zech R
    Biochem Pharmacol; 1983 Jun; 32(11):1693-9. PubMed ID: 6870909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catalytic properties of the acetylcholinesterase from human erythrocytes].
    Abramovich TD; Borzunina AM; Golub TL; Eremeeva AM; Zhukovskiĭ IuG
    Biokhimiia; 1973; 38(6):1137-43. PubMed ID: 4802004
    [No Abstract]   [Full Text] [Related]  

  • 13. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.
    Gray AP
    Drug Metab Rev; 1984; 15(3):557-89. PubMed ID: 6386410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Restoration of acetylcholinesterase activity in animals intoxicated with pinacolyl-methylphosphonofluoridate].
    Faff J
    Acta Physiol Pol; 1972; 23(4):685-95. PubMed ID: 5080267
    [No Abstract]   [Full Text] [Related]  

  • 15. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
    Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
    Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cholinesterase reactivity of the Komandor squid Berryteuthis magister. Substrates and organophosphorus inhibitors].
    Rozengart EV
    Zh Evol Biokhim Fiziol; 1996; 32(5):576-83. PubMed ID: 9092237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring exposure of passerines to acephate, dicrotophos, and malathion using cholinesterase reactivation.
    Maul JD; Farris JL
    Bull Environ Contam Toxicol; 2004 Oct; 73(4):682-9. PubMed ID: 15389333
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kinetics of hydrolysis of the phenyl analog of acetylcholine under the action of cholinesterase from horse serum and acetylcholinesterase from bovine erythrocytes].
    Brestkin AP; Brik IL; Teplov NE
    Biokhimiia; 1968; 33(5):1059-68. PubMed ID: 5703735
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of environment on allosteric properties of acetylcholinesterase].
    Freĭdlin TS; Balashova EK; Rozengart VI; Sherstobitov OE
    Biokhimiia; 1977 Sep; 42(9):1626-30. PubMed ID: 20999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.